英文名称 |
中文名称 |
CAS |
Benhexol impurity 13
|
苯海索杂质13 |
|
Fluticasone Furoate Impurity 9
|
糠酸氟替卡松杂质9 |
|
Macitentan Impurity 42
|
马西替坦杂质42 |
|
L-salbutamol impurity B
|
左旋沙丁胺醇杂质B(指定BP 852) |
|
Vilanterol Impurity 44
|
维兰特罗杂质44 |
24085-19-6 |
Melphalan lmpurity 7
|
美法仑杂质7 |
|
Melphalan lmpurity 5
|
美法仑杂质5 |
|
Mupirocin Impurity 5
|
莫匹罗星杂质5 |
|
Fusidic Acid EP Impurity B
|
夫西地酸EP杂质B |
|
Milbemycin EP impurities D
|
米尔贝霉素EP杂质D |
|
Bumetanide Impurity 24
|
布美他尼杂质24 |
|
Molnupiravir Impurity 19
|
莫那匹韦杂质19 |
|
Drotaverine Impurity 23
|
屈他维林杂质23 |
|
Avibatan genotoxic Impurity 1
|
阿维巴坦基因毒杂质1 |
|
Moxonidine adulterant(Impuriy) A
|
莫索尼定掺杂物(杂质)(指定品牌EP Y0000222) |
|
Timolol EP Impurity J
|
噻吗洛尔EP杂质J |
|
Tranexamic acid impurity standard
|
氨甲环酸杂质标准(指定品牌BP 货号734) |
|
Mupirocin EP Impurity H
|
莫匹罗星EP杂质H |
|
Lansoprazole impurity II (specified brand: Chinese Academy cat. No: 510047)
|
兰索拉唑杂质Ⅱ(指定品牌:中检院 货号:510047) |
|
Drotaverine Impurity 26
|
屈他维林杂质26 |
|
Fenoterol system suitability CRS
|
非诺特罗系统适用性CRS(指定品牌EP Y0002102) |
|
Ibuprofen Impurity 69(mixture)
|
布洛芬杂质69(混合物) |
|
Tranexamic Acid Impurity F CRS(designated brand EP Y0002154)
|
氨甲环酸杂质F CRS(指定品牌EP Y0002154) |
|
Ceftriaxone impurity 29(ene Isomer)
|
头孢曲松杂质29(烯异构体) |
|
Rifampicin impurities5
|
利福平杂质5 |
13292-53-0 |
Lurasislone Impurity 18
|
鲁拉西酮杂质18 |
1807983-62-5 |
N-(2-Quinoxaline)-sulfaquinoxalin.
|
N-(2-喹喔啉)-磺胺喹喔啉。 |
|
Relugolix Impurity 15
|
瑞卢戈利杂质15 |
|
Benhexol impurity 14
|
苯海索杂质14 |
|
Bumetanide Impurity 26
|
布美他尼杂质26 |
|
Ceftriaxone sodium impurity H
|
头孢曲松钠杂质H |
|
1-nitroso-1H-benzotriazole
|
1-亚硝基-1H-苯并三唑 |
|
Fluticasone Furoate Impurity 10
|
糠酸氟替卡松杂质10 |
11111-34-5 |
Mupirocin Impurity 6
|
莫匹罗星杂质6 |
|
Molnupiravir Impurity 16
|
莫那匹韦杂质16 |
2346620-53-7 |
Tranexamic acid impurity F
|
氨甲环酸杂质F(指定品牌EP Y0002153) |
|
Bumetanide Impurity 23
|
布美他尼杂质23 |
|
Drotaverine Impurity 25
|
屈他维林杂质25 |
|
Avibatan genotoxic Impurity 2
|
阿维巴坦基因毒杂质2 |
|
Vigabatrin Impurity 18
|
氨己烯酸杂质18 |
|
Amphotericin B Impurity E
|
两性霉素B杂质 E |
|
Isoproterenol Impurity 27
|
异丙肾上腺素杂质27 |
|
Montelukast dicyclohexylamine
|
孟鲁司特二环己胺(指定EP 货号Y0001436) |
|
Phenylhexol impurity 4
|
苯海索杂质4 |
|
Famotidine Impurity 26
|
法莫替丁杂质26 |
95853-46-6 |
Bumetanide Impurity 25
|
布美他尼杂质25 |
|
Carbazochrome Sodium Sulfonate Impurity 30
|
卡络磺钠杂质30 |
|
Drotaverine Impurity 27
|
屈他维林杂质27 |
|
Fluconazole triazole ethyl impurity
|
氟康唑三唑乙基杂质(氟康唑杂质25) |
|
Siliconized microcrystalline cellulose
|
硅化微晶纤维素(指定USP货号:1098399) |
|
Dydrogesterone Impurity 14
|
地屈孕酮杂质14 |
|
Losartan system suitability
|
洛沙坦系统适用性CRS |
|
Benidipine Impurity I
|
贝尼地平杂质I |
|
Methotrexate Impurity 26
|
甲氨蝶呤杂质26 |
|
Febuxostat Impurity 32
|
非布索坦杂质32 |
1805770-41-5 |
Betaxolol impurity a
|
倍他洛尔杂质A(指定) |
|
Phenylhexol impurity 8
|
苯海索杂质8 |
127865-20-7 |
Estradiol valerate impurity 10
|
戊酸雌二醇杂质10 |
|
Vitamin B2 impurity 1
|
维生素B2杂质1 |
|
Ceftriaxone impurity 30 (olefin isomer disodium salt)
|
头孢曲松杂质30(烯异构体二钠盐) |
|
4-{4-fluoro-3-[(4-nitrosopiperazin-1-yl)carbonyl]benzyl}phthalazin-1(2H)-one
|
4-{4-氟-3-[(4-亚硝基哌嗪-1-基)羰基]苄基}酞嗪-1(2H)-酮 |
|
Valsartan Impurity 3
|
缬沙坦杂质3 |
|
Milbemycin EP impurities F
|
米尔贝霉素EP杂质F |
|
Rifampicin impurities6
|
利福平杂质6 |
|
Bumetanide Impurity 22
|
布美他尼杂质22 |
|
Molnupiravir Impurity 17
|
莫那匹韦杂质17 |
|
Avibatan genotoxic Impurity 3
|
阿维巴坦基因毒杂质3 |
|
Fluticasone Furoate Impurity 8
|
糠酸氟替卡松杂质8 |
|
Milbemycin EP impurities I
|
米尔贝霉素EP杂质I |
|
8s-isopropyl-3 β- Mm hydroxymethylammonium bromide
|
8s-异丙基-3β-羟基甲基溴化铵(指定BP 626) |
|
Omeprazole Related Compound F and G Mixture
|
奥美拉唑相关物质F和G混合物 (货号1478491) |
|
Lilalitine impurity 1
|
利拉利汀杂质1 |
|
Bepotastine Impurity 3
|
贝他斯汀杂质3 |
210095-66-2 |
Ofloxacin impurity E
|
氧氟沙星杂质E (货号O0120050) |
|
Drotaverine Impurity 13
|
屈他维林杂质13 |
|
Drotaverine Impurity 28
|
屈他维林杂质28(氮氧化物) |
|
Montelukast methanol impurities1
|
孟鲁司特酮甲醇杂质1(指定TLC货号?M-3014) |
|
Nimesulide impurity D (control article)
|
尼美舒利杂质D(对照品)(指定EP货号:N0845008) |
|
Dydrogesterone Impurity 15
|
地屈孕酮杂质15 |
|
Ethyl cinnamate impurity 1
|
肉桂酸乙酯杂质1 |
|
Melphalan lmpurity 3
|
美法仑杂质3 |
896715-19-8 |
Vitamin B2 impurity 3
|
维生素B2杂质3 |
64480-68-8 |
Tofatinib Impurity 40
|
托法替尼杂质40 |
|
Ticargrelor impurity 7
|
替格瑞洛杂质7 |
2588537-76-0 |
Cabergoline Impurity 24
|
卡麦角林杂质24 |
591-87-7 |
Mupirocin EP Impurity G
|
莫匹罗星EP杂质G |
|
Salicylic acid tablets standard (designated brand: Chinese Academy cat. No: 100103)
|
水杨酸片标准品(指定品牌:中检院 货号:100103) |
|
Prednisolone Phosphate USP Impurity E
|
磷酸泼尼松龙USP杂质E |
|
Molnupiravir Impurity 21
|
莫那匹韦杂质21 |
|
Fosfomycin tromethamine Impurity5(Disodium Salt)
|
磷霉素氨丁三醇杂质5(二钠盐) |
|
Ticagrelor system suitability for CRS
|
替卡格雷系统适用性CRS(指定) |
|
Sofosbuvir Impurity 32
|
索非布韦杂质32 |
1157884-58-6 |
Melphalan lmpurity 6
|
美法仑杂质6 |
1951445-22-9 |
Cefmetazole Impurity 21
|
头孢美唑杂质21 |
|
8s-isopropyl-3β-hydroxytropanium bromide
|
8s-异丙基-3β-羟基托烷溴化物(指定BP货号626) |
|
Methotrexate EP Impurity G
|
甲氨蝶呤EP杂质G |
2519848-42-9 |
Gefitinib Impurity 69
|
吉非替尼杂质69 |
|
Chlorpromazine impurity D
|
氯丙嗪杂质D CRS(指定品牌EP Y0000479) |
|
(2-hydroxy-2 - (3-hydroxyphenyl) ethyl) (methyl) amino) - 4-oxobuty-2-enoic acid
|
(2-羟基-2-(3-羟基苯基)乙基)(甲基)氨基)-4-氧代丁-2-烯酸 |
|
Salbutamol impurity B (designated brand BP cat. No: 852)
|
沙丁胺醇杂质B(指定品牌BP 货号:852) |
|